Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,051.68 +41.08 (+0.82%) Dow
38,399.15 +159.17 (+0.42%) Nasdaq
15,625.51 +174.20 (+1.13%) Bitcoin USD
66,900.81 +665.07 (+1.00%) CMC Crypto 200
1,430.46 +15.70 (+1.11%)
ABBV Jan 2025 145.000 put
| Previous close | 3.9800 |
| Open | 3.9800 |
| Bid | 3.3000 |
| Ask | 3.9500 |
| Strike | 145.00 |
| Expiry date | 2025-01-17 |
| Day's range | 3.9800 - 3.9800 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.96k |
PR NewswireAllergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is offering consumers an opportunity to be featured in upcoming campaigns for their biggest brands, including BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, the Allergan Aesthetics loyalty rewards program. Beginning today, consumers—including existing patients and those who are considering aesthetic treatment—can apply for a chance to be included in future brand campaigns. The first Allergan Aesthetics open casting call for BO
ZacksAbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Investor focus is likely to be on the sales of AbbVie's (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports first-quarter results.
ZacksEarnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
